Sarcopenia in acute ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at muscle loss (sarcopenia) in people who have had an acute ischemic stroke. It aims to understand how muscle wasting affects recovery, which may help improve care for stroke patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older
- You had an acute ischemic stroke confirmed by a CT or MRI scan
- You arrive at the hospital within 72 hours of the stroke
- You are able to give written consent and have a phone for follow-up
- You do not have major limb amputation, severe contractures, stage IV cancer, long-term steroid use, or certain other conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how thigh muscle thickness measured by ultrasound relates to muscle weakness and fear of movement in people who have had a stroke. It may help find better ways to assess muscle health and recovery.
This study looks at muscle loss (sarcopenia) that can happen quickly in older adults during a hospital stay. It aims to understand how common it is and what factors might contribute, which could help improve care for patients.
This study looks at muscle loss (sarcopenia) in people with multiple sclerosis. It aims to understand what factors are linked to muscle loss, which could help improve care.
This study looks at how common muscle loss (sarcopenia) is in people with knee osteoarthritis and what factors are linked to it. It may help doctors better understand and manage muscle weakness in knee OA patients.
This study checks for muscle loss (sarcopenia) in people aged 65 or older who are waiting for hip replacement surgery. It aims to see how common muscle loss is and may help improve care before and after surgery.
This study looks at the reasons for age-related muscle loss (sarcopenia) in people with heart failure. It may help researchers understand what is causing muscle weakness and how it could be treated in the future.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.